A Chinese bio-pharmaceutical company.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 13, 2017 | Series A | $15M | 3 |
|
— | Detail |
| Jun 26, 2017 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
|
|
Yes | Series A |
National Science Foundation
|
Yes | Grant |
JiangSu QianRong Assets Management
|
— | Series A |